HCP Live July 4, 2024
Our dermatology FDA recap for the first half of 2024 includes our top 5 approvals, 3 decisions to watch in the second half of 2024, and a podcast episode with James Del Rosso, DO
Led by a flood of biologic therapies becoming available and others progressing within the therapeutic pipeline, the field of dermatology finds itself in the midst of a watershed moment for a slew of dermatologic conditions. To celebrate and recap the advancements occurring in the first half of 2024, the editorial team of HCPLive Dermatology sat down with James Del Rosso, DO, research director of JDR Dermatology Research and president of the American Acne and Rosacea Society, for more perspective on pipeline movement.
Del Rosso, who also...
Today's Sponsors
Today's Sponsor